H.R. 5585 117th Congress
ARPA–H Act
- Health
- Sponsor: Rep. Eshoo, Anna G. [D-CA-18]
- Congress.gov ↗
Latest action, Jun 23, 2022: Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
How the Senate voted
The Senate hasn't taken a roll call on this bill in the Congresses covered.
66 cosponsors
Sponsored by Rep. Eshoo, Anna G. [D-CA-18] (Democrat). Cosponsors by party, House members included:
- Democrats
- Republicans
- Independents
Cosponsors
63 D · 3 R
- Democrat
- Republican
- Independent
Referred to: Senate: Health, Education, Labor, and Pensions Committee; House: Energy and Commerce Committee
Who lobbied on it
Clients whose quarterly lobbying reports named it, each quarter.
The clients with the most reports naming it. A report's amount covers all of that client's lobbying in the quarter, not just this bill.
ACADEMY FOR RADIOLOGY & BIOMEDICAL IMAGING RESEARCH
5 reports
5 reports
CENTER FOR LYME ACTION
EDMONDSON HOPKINS GROUP
5 reports
CHILDREN'S HEALTHCARE OF ATLANTA
ARENTFOX SCHIFF LLP
5 reports
5 reports
5 reports
5 reports
5 reports
5 reports
NATIONAL VENTURE CAPITAL ASSOCIATION
MEHLMAN CONSULTING, INC.
5 reports
5 reports
THE CHILDREN'S HOSPITAL OF PHILADELPHIA
ARENTFOX SCHIFF LLP
5 reports
All 25 of 85 clients
| Client | Lobbying firm | Reports | Reports totaling | From | To | Senate |
|---|---|---|---|---|---|---|
| ACADEMY FOR RADIOLOGY & BIOMEDICAL IMAGING RESEARCH | 5 | $51K | Q4 2021 | Q3 2022 | yes | |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | 5 | $4.8M | Q4 2021 | Q3 2022 | yes | |
| ASSOCIATION OF AMERICAN UNIVERSITIES | 5 | $460K | Q4 2021 | Q3 2022 | yes | |
| CENTER FOR LYME ACTION | EDMONDSON HOPKINS GROUP | 5 | $35K | Q4 2021 | Q3 2022 | yes |
| CHILDREN'S HEALTHCARE OF ATLANTA | ARENTFOX SCHIFF LLP | 5 | $0 | Q4 2021 | Q3 2022 | yes |
| CHILDREN'S HEALTHCARE OF ATLANTA | 5 | $603K | Q4 2021 | Q3 2022 | yes | |
| DANA-FARBER CANCER INSTITUTE | 5 | $481K | Q4 2021 | Q3 2022 | yes | |
| GSK (FKA GLAXOSMITHKLINE INC.) | 5 | $5.5M | Q4 2021 | Q3 2022 | yes | |
| NATIONAL TREASURY EMPLOYEES UNION | 5 | $1.2M | Q4 2021 | Q3 2022 | yes | |
| NATIONAL VENTURE CAPITAL ASSOCIATION | 5 | $3.8M | Q4 2021 | Q3 2022 | yes | |
| NATIONAL VENTURE CAPITAL ASSOCIATION | MEHLMAN CONSULTING, INC. | 5 | $0 | Q4 2021 | Q3 2022 | yes |
| PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA | 5 | $35.5M | Q4 2021 | Q3 2022 | yes | |
| RUTGERS THE STATE UNIVERSITY OF NEW JERSEY | 5 | $350K | Q4 2021 | Q3 2022 | yes | |
| STANFORD UNIVERSITY | 5 | $450K | Q4 2021 | Q3 2022 | yes | |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | ARENTFOX SCHIFF LLP | 5 | $0 | Q4 2021 | Q3 2022 | yes |
| THE CHILDREN'S HOSPITAL OF PHILADELPHIA | 5 | $740K | Q4 2021 | Q3 2022 | yes | |
| AKEBIA THERAPEUTICS, INC. | 4 | $1.3M | Q1 2022 | Q3 2022 | yes | |
| AMERICAN HEART ASSOCIATION | 4 | $370K | Q1 2022 | Q3 2022 | yes | |
| ASSOCIATION OF AMERICAN MEDICAL COLLEGES | RAMPY NORTHRUP LLC | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| ASTRAZENECA PHARMACEUTICALS LP | RAMPY NORTHRUP LLC | 4 | $0 | Q1 2022 | Q3 2022 | — |
| BIOTECHNOLOGY INNOVATION ORGANIZATION | 4 | $13.3M | Q1 2022 | Q3 2022 | yes | |
| HARMONY BIOSCIENCES, LLC | RAMPY NORTHRUP LLC | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| JOHNSON & JOHNSON SERVICES, INC. | RAMPY NORTHRUP LLC | 4 | $0 | Q1 2022 | Q3 2022 | yes |
| KAISER FOUNDATION HEALTH PLAN INC | 4 | $5.7M | Q1 2022 | Q3 2022 | yes | |
| PHARMACEUTICAL RESEARCH & MANUFACTURERS OF AMERICA INC | COVINGTON & BURLING LLP | 4 | $0 | Q1 2022 | Q3 2022 | yes |